Vincerx Pharma (VINC)
(Delayed Data from NSDQ)
$0.65 USD
-0.03 (-4.43%)
Updated Jul 29, 2024 03:59 PM ET
After-Market: $0.64 -0.01 (-1.52%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for Vincerx Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -40.16 | -65.37 | -39.31 | -10.72 | 0.00 |
Depreciation/Amortization & Depletion | 0.29 | 0.94 | 0.34 | 0.02 | 0.00 |
Net Change from Assets/Liabilities | -4.19 | -1.02 | 5.61 | -0.96 | 0.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.61 | 5.84 | -0.05 | 9.38 | 0.00 |
Net Cash From Operating Activities | -40.45 | -59.60 | -33.40 | -2.28 | 0.00 |
Property & Equipment | 0.00 | 0.00 | -0.26 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 41.50 | -40.58 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -5.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 41.50 | -40.58 | -5.26 | 0.00 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.11 | 0.28 | 88.45 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 64.07 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.11 | 0.28 | 88.45 | 64.07 | 0.00 |
Effect of Exchange Rate Changes | -0.04 | 0.07 | -0.02 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 1.12 | -99.83 | 49.77 | 61.79 | 0.00 |
Cash at Beginning of Period | 11.73 | 111.56 | 61.79 | 0.00 | 0.00 |
Cash at End of Period | 12.85 | 11.73 | 111.56 | 61.79 | 0.00 |
Diluted Net EPS | -1.89 | -3.11 | -2.29 | -2.04 | NA |
Fiscal Year End for Vincerx Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -12.43 | -40.16 | -35.21 | -25.49 |
Depreciation/Amortization & Depletion | NA | 0.26 | 0.29 | 0.05 | -0.11 |
Net Change from Assets/Liabilities | NA | -1.31 | -4.19 | -0.38 | -2.06 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 5.73 | 3.61 | 3.09 | 1.87 |
Net Cash From Operating Activities | NA | -7.74 | -40.45 | -32.43 | -25.79 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 41.50 | 35.75 | 20.69 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 41.50 | 35.75 | 20.69 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.01 | 0.11 | 0.10 | 0.10 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.01 | 0.11 | 0.10 | 0.10 |
Effect of Exchange Rate Changes | NA | 0.07 | -0.04 | 0.00 | 0.02 |
Net Change In Cash & Equivalents | NA | -7.66 | 1.12 | 3.42 | -4.98 |
Cash at Beginning of Period | NA | 12.85 | 11.73 | 11.73 | 11.73 |
Cash at End of Period | NA | 5.19 | 12.85 | 15.15 | 6.75 |
Diluted Net EPS | NA | -0.58 | -0.23 | -0.46 | -0.52 |